Message Font: Serif | Sans-Serif
No. of Recommendations: 0
Well I'm not sure if I am the only fool who has NMR in their portfolio. I purchased it prior to the split at 3/916 hoping the 1 for 3 would make the stock attractive to the institutional investors. Well the split brought the stock up over 10.00 but then the market tanked and the stock is down to 9.00. My main concern is now that the stock is under $10.00 will the institutional buyers still be interested in NMR? What is the lowest stock price most institutional buyers will consider purchasing a small cap like Nielsen? I know the company is on solid ground. Has virtually a monopoly (SRI's test sample in Philly has yet to produce data and is in trouble) a small amount of debt from IMS health and very steady revenue flow... Logic I guess would dictate I hold on.... What do you guys think??????

Print the post  


When Life Gives You Lemons
We all have had hardships and made poor decisions. The important thing is how we respond and grow. Read the story of a Fool who started from nothing, and looks to gain everything.
Contact Us
Contact Customer Service and other Fool departments here.
Work for Fools?
Winner of the Washingtonian great places to work, and Glassdoor #1 Company to Work For 2015! Have access to all of TMF's online and email products for FREE, and be paid for your contributions to TMF! Click the link and start your Fool career.